28 results
424B5
IMNM
Immunome, Inc.
14 Feb 24
Prospectus supplement for primary offering
4:09pm
partnership or arrangement classified as a partnership for U.S. federal income tax purposes holds our common stock, the tax treatment of a partner
424B5
IMNM
Immunome, Inc.
13 Feb 24
Prospectus supplement for primary offering
4:36pm
plans.
If any partnership or arrangement classified as a partnership for U.S. federal income tax purposes holds our common stock, the tax treatment
8-K/A
EX-99.1
IMNM
Immunome, Inc.
22 Nov 23
Report of Independent Auditors
4:02pm
Classification
The Company has classified its convertible preferred stock as temporary equity on the balance sheet as the shares can be redeemed upon
8-K/A
EX-99.2
IMNM
Immunome, Inc.
22 Nov 23
Report of Independent Auditors
4:02pm
Total financial assets
Money market funds are measured at fair value on a recurring basis using quoted prices and are classified as Level 1 … . Investments are measured at fair value based on inputs other than quoted prices that are derived from observable market data and are classified as Level 2
424B3
bid9o4
28 Aug 23
Prospectus supplement
9:10am
S-4/A
8bvmg4wpy 8prwg8ofm
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4/A
EX-10.47
fdl8434
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4/A
EX-10.48
hz02 cceeigyy4nnzd
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4/A
EX-10.46
qzqmpbou
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4
yuyoa5t9
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
425
EX-2.1
lzite
29 Jun 23
Business combination disclosure
9:10am
8-K
EX-2.1
82jdi6s6 jc
29 Jun 23
Immunome and Morphimmune Announce Definitive Merger Agreement
9:08am